Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mitochondrial oxidants promote platelet activation and thrombotic susceptibility in prediabetes
Azaj Ahmed, Pooja Yadav, Melissa Jensen, Katharine Geasland, Jagadish Swamy, Douglas R. Spitz, E. Dale Abel, Diana Jalal, Sanjana Dayal
Azaj Ahmed, Pooja Yadav, Melissa Jensen, Katharine Geasland, Jagadish Swamy, Douglas R. Spitz, E. Dale Abel, Diana Jalal, Sanjana Dayal
View: Text | PDF
Research Article Hematology Vascular biology

Mitochondrial oxidants promote platelet activation and thrombotic susceptibility in prediabetes

  • Text
  • PDF
Abstract

Recent studies suggest prediabetes is an independent risk factor for cardiovascular thrombotic events. However, the mechanisms that may promote platelet activation and thrombosis in prediabetes remain elusive. To determine mechanisms linking prediabetes and thrombosis as a function of age, we recruited military veterans with prediabetes and veterans who were normoglycemic, in young and middle-age groups. Compared with normoglycemic participants, platelets from those with prediabetes exhibited increased activation, mitochondrial oxidant load, mitochondrial membrane hyperpolarization, and greater thrombus formation ex vivo regardless of age. Preincubation of platelets with mitochondria-targeted antioxidants, such as SOD mimetic or mitoquinol (MitoQ), rescued this prothrombotic phenotype. These phenotypes were recapitulated in C57BL6/J mice exhibiting early onset of glucose intolerance when fed a high-fat (HF) diet for 2 weeks. Treatment of HF-fed mice with a SOD mimetic or MitoQ, or genetic overexpression of catalase within mitochondria, not only lowered mitochondrial oxidants, hyperpolarization, Ca2+ levels, and platelet activation but also protected against increased potential for carotid and pulmonary thrombosis. We also observed a bidirectional regulation of platelet activation by Ca2+ and mitochondrial oxidants. These findings support the idea that mitochondrial oxidant–dependent platelet activation induces a prothrombotic state in clinical prediabetes and preclinical models of short-term glucose intolerance and can be reversed by mitochondria-targeted antioxidants.

Authors

Azaj Ahmed, Pooja Yadav, Melissa Jensen, Katharine Geasland, Jagadish Swamy, Douglas R. Spitz, E. Dale Abel, Diana Jalal, Sanjana Dayal

×

Figure 7

mCAT-Tg mice are protected from enhanced platelet mito-oxidants, platelet activation, and susceptibility to carotid artery and pulmonary thrombosis after short-term HF diet feeding.

Options: View larger image (or click on image) Download as PowerPoint
mCAT-Tg mice are protected from enhanced platelet mito-oxidants, platele...
mCAT-Tg mice and wild-type littermates were fed chow or an HF diet for 2 weeks. Washed platelets were prepared for quantifying (A) mito-oxidants, (B) αIIbβ3 activation, and (C) P-selectin expression after activation with 0.05 U/mL thrombin and 50 ng/mL convulxin for A, and with 0.05 U/mL thrombin for B and C, and analyzed via flow cytometry. (D) Time to stable occlusion of the carotid artery after photochemical injury. Data are presented as median with 95% CI and were analyzed by Kruskal-Wallis test with Dunn’s post hoc test for multiple-group comparisons (n = 8–10 per group). (E) Survival curve depicting time to death after infusion with 0.5 μg/g collagen. Data were analyzed using the Mantel-Cox log-rank test. The comparison between wild-type and mCAT-Tg mice fed the HF diet is shown with a blue bracket and between chow- and HF-fed wild-type groups is shown as a brown bracket with blue fill (n = 11–14 per group). Data for A–C are presented as mean ± SEM and analyzed using 2-way ANOVA with Tukey’s test for multiple-group comparisons (n = 6 per group). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts